How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

Anthropic says recursive self-improvement is their chosen path for AI advancing AI. I explain the ins and outs. An AI Insider ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

In January, 1923, Lee Strasberg went to Al Jolson’s 59th Street Theatre to see “Tsar Fyodor Ivanovich,” a nineteenth-century Russian play about sixteenth-century Russian politics, performed, in ...

Recursive Superintelligence has raised $650 million at a $4.65 billion valuation in a funding round led by GV and Greycroft, according to the company. The round also included participation from AMD ...

In The Lancet in 1971, Julian Tudor Hart gave medicine one of its most important insights: the availability of medical care tends to vary inversely with need—the inverse care law.1 Half a century ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Terms apply to American Express benefits and offers. Visit americanexpress.com to learn more. All payment methods involve some degree of risk, whether from human error, financial fraud or identity ...

National security, unlocked. Each Thursday, host Mary Louise Kelly and a team of NPR correspondents discuss the biggest national security news of the week. With decades of reporting from battlefields ...